Ligation News and Research

RSS
Hazards of dietary supplements, new birth control device explored

Hazards of dietary supplements, new birth control device explored

First Edition: December 23, 2013

First Edition: December 23, 2013

Teleflex net revenues increase 12.4% to $413.8 million in third quarter 2013

Teleflex net revenues increase 12.4% to $413.8 million in third quarter 2013

Immunologic checkpoint inhibitor shows promise in malignant mesothelioma

Immunologic checkpoint inhibitor shows promise in malignant mesothelioma

Revised Medicaid sterilization policy supports minority women at risk for unintended pregnancies

Revised Medicaid sterilization policy supports minority women at risk for unintended pregnancies

Researchers develop therapeutic algorithm to study outcomes in epistaxis management

Researchers develop therapeutic algorithm to study outcomes in epistaxis management

Women who undergo surgical treatment for endometriosis have lower risk of ovarian cancer

Women who undergo surgical treatment for endometriosis have lower risk of ovarian cancer

Biologic changes after delivery may prevent development of chronic pain

Biologic changes after delivery may prevent development of chronic pain

New England Biolabs launches new NEBNext Ultra kits at ASHG annual meeting

New England Biolabs launches new NEBNext Ultra kits at ASHG annual meeting

Two new EU Member States now represented within TRANSVAC services platform

Two new EU Member States now represented within TRANSVAC services platform

Prognosis still poor for EVB in cirrhosis

Prognosis still poor for EVB in cirrhosis

Roughly two in five women in the U.S. do not use any form of birth control: Survey

Roughly two in five women in the U.S. do not use any form of birth control: Survey

DNA synthesis methods: an interview with Clemens Richert

DNA synthesis methods: an interview with Clemens Richert

Low platelet count not associated with patent ductus arteriosus

Low platelet count not associated with patent ductus arteriosus

Life Technologies introduces three next generation genetic engineering kits

Life Technologies introduces three next generation genetic engineering kits

Illumina's new patent infringement suit targets Complete Genomics' cPal read technology

Illumina's new patent infringement suit targets Complete Genomics' cPal read technology

Teleflex, Premier enter new agreements for ligation and stapling products, suture and trocars

Teleflex, Premier enter new agreements for ligation and stapling products, suture and trocars

Viewpoints: The constitution and birth control; War on Wyden

Viewpoints: The constitution and birth control; War on Wyden

Survey shows low awareness for non-surgical permanent birth control methods

Survey shows low awareness for non-surgical permanent birth control methods